Anti-inflammatory interventions—what has worked, not worked, and what may work in the future
Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation
Therapeutics targeting the inflammasome after central nervous system injury
Autoimmune disease and vaccination: impact on infectious disease prevention and a look at future applications
Therapeutics targeting innate immune/inflammatory responses through the interleukin-6/JAK/STAT signal transduction pathway in patients with cancer
Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer
Angiogenic factors and inflammation in steroid-refractory acute graft-vs-host disease
Therapeutics targeting inflammation in the immune reconstitution inflammatory syndrome
Pathway-based approaches to the treatment of inflammatory bowel disease
Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidence
Targeting the inflammasome in rheumatic diseases
Targeting inflammation in the prevention of cardiovascular disease in patients with inflammatory arthritis
Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges
Interferon regulatory factor 5 in human autoimmunity and murine models of autoimmune disease
Therapeutic targeting of acute lung injury and acute respiratory distress syndrome
Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease
Therapeutics targeting persistent inflammation in chronic kidney disease
Innate inflammation in type 1 diabetes
Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction
Targeting inflammation in metabolic syndrome
Inflammatory targets of therapy in sickle cell disease